Many of the biological changes occurring in the endometrium during the mens
trual cycle bear a striking resemblance to those associated with inflammato
ry and reparative processes. Hence, it would not be surprising to find that
cytokines known for their proinflammatory properties, such as interleukin-
1 (IL-l), could play a key role in the physiology of this tissue and that t
heir action would be tightly controlled by local mechanisms. In the present
study, immunohistochemical and Western blot analyses show that in normal w
omen (n = 39), the endometrial tissue expresses, in a cycle-dependent manne
r, the IL-1 receptor type II (IL-1RII), a molecule of which the only biolog
ical property known to date is that of capturing IL-1, inhibiting thereby i
ts binding to the functional type I IL-1 receptor. IL-RII immunostaining wa
s particularly intense within the lumen of the glands and at the apical sid
e of surface epithelium, Interestingly, the intensity of staining was marke
dly less pronounced in the endometrium of women with endometriosis(n = 54),
a disease believed to arise from the abnormal development of endometrial t
issue outside the uterus, especially in the early stages of the disease (st
ages I and II). This study is the first to show the local expression in end
ometrial tissue of IL-1RII, a potent and specific down-regulator of IL-1 ac
tion and its decreased expression in women suffering from endometriosis.